Skip to main content
. 2022 Aug 28;58(9):1169. doi: 10.3390/medicina58091169

Table 2.

Patient outcomes.

Tenecteplase
N = 45
Alteplase
N = 139
OR (95% CI) p Value
Discharge mRS, N (%) 0–2 18/45 (40) 31/139 (22.3) 0.43 (0.21–0.88) 0.02
90-day mRS, N (%) 3 2/37 (5.4) 36/111 (32.4) 8.40 (1.91–36.88) <0.001

mRS, modified Rankin Scale; OR, odds ratio; Confidence interval, CI.